Envisu Spectral Domain Ophthalmic Imaging System (Sdois)
Ophthalmoscope, Ac-Powered. 510(k) K120057, from Bioptigen, Inc. (Durham, NC). Product code HLI, class 2.
As of Nov 19, 2026, K120057 is an FDA 510(k) held by Bioptigen, Inc., substantially equivalent on May 11, 2012 after 123 days, with no recalls tied to it in FDA's recall database.
- Review time: 123 days
- Recalls: 0
- Cited as a predicate by: 3 devices
Bioptigen Envisuâ„¢ Spectral Domain Ophthalmic Imaging System (Envisuâ„¢ SDOIS) is intended to acquire, process, display and save depth-resolved images of ocular tissue microstructure using Spectral Domain Optical Coherence Tomography (SDOCT). The Envisuâ„¢ SDOIS is indicated for use as an aid in the diagnosis of physiologic and pathologic conditions of the eye through non-contact optical imaging.
- Bioptigen Spectral Domain Ophthalmic Imaging SystemK063343 · Bioptigen, Inc. · Dec 13, 2006
- SPECTRALIS with Flex ModuleK241163 · Heidelberg Engineering GmbH · Oct 11, 2024
- EnFocus 2300, EnFocus 4400K150722 · Bioptigen, Inc. · Dec 2, 2015
- OCT-CameraK142953 · Optomedical Technologies GmbH · Mar 4, 2015
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 9, 2012
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files